Medicare Rx “Fallback” Plans Ensured Small Role Under CMS Rule

Entities administering a Medicare prescription drug "fallback" plan in a single U.S. region will be prohibited from bidding as stand-alone PDPs anywhere nationwide during the three-year contract term, CMS' proposed regulation says